¥ï¥¯¥Á¥ó¤Î¸ú²Ì¤ò¹â¤á¤ë¤¿¤á¤Ë´Þ¤Þ¤ì¤Æ¤¤¤ë¥¢¥¸¥å¥Ð¥ó¥È¡ÊÌȱÖÁý¶¯ºÞ¡Ë¡£
¿··¿¥¤¥ó¥Õ¥ë¤Î»þ¤Ë¾¯¤·ÃíÌܤµ¤ì¤Þ¤·¤¿¤¬¡¢HPV¥ï¥¯¥Á¥ó¤Ç¤Ï¤¢¤Þ¤êÏÃÂê¤Ë¤Ê¤ê¤Þ¤»¤ó¡£
ÆüËܤÇǧ²Ä¤µ¤ì¤Æ¤¤¤ëHPV¥ï¥¯¥Á¥ó¤Î¥µ¡¼¥Ð¥ê¥Ã¥¯¥¹¤Ë´Þ¤Þ¤ì¤Æ¤¤¤ë¥¢¥¸¥å¥Ð¥ó¥È¤¬¡¢½÷À¤ÎÌȱ֤˱ƶÁ¤òÍ¿¤¨¡¢Î®»º¤Î¥ê¥¹¥¯¤Ë¤Ä¤Ê¤¬¤ë¤«¤É¤¦¤«¤Ë¤Ä¤¤¤Æ¤ÎÄ´ºº¤Î·ë²Ì¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
Ä´ºº¤Ï14¥ö¹ñ¤Î15-25ºÐ½÷À26000¿Íµ¬ÌϤǹԤï¤ì¡¢4ǯ¤Î´Ñ»¡´ü´ÖÃæ¤Ë3599¤ÎÇ¥¿±¤¬¤ª¤¤Þ¤·¤¿¡£
Á´ÂΤȤ·¤Æ¤ÏÀܼﷲ¤ÈÈóÀܼﷲ¤Îή»º¤Î¥ê¥¹¥¯¤Ë¤Á¤¬¤¤¤Ï¤Ê¤·¡£¡Ê11.5¡ó¡¡VS¡¡10.2¡ó¡Ë¡£
ºÇ¸å¤ÎÀܼ狼¤é£³¥ö·î°ÊÆâ¤Îή»º¤Î¥ê¥¹¥¯¤ÏÀܼﷲ¤¬ÈóÀܼﷲ¤è¤ê¤â¹â¤¤¤³¤È¤¬»ØŦ¤µ¤ì¤Þ¤·¤¿¡Ê14.7¡ó VS¡¡9.1¡ó¡Ë¡£
¤¤¤º¤ì¤Ë¤·¤Æ¤â¡¢¥ï¥¯¥Á¥óÀܼïÁ°¸å¤Ç¤¢¤Ã¤Æ¤â¡Ö¥³¥ó¥É¡¼¥à¤ò¤Ï¤º¤µ¤Ê¤¤¤è¤¦¤Ë¡×¤ÏÈòÇ¥¤Ë¤â´¶À÷ͽËɤˤâ½ÅÍס£
¿··¿¥¤¥ó¥Õ¥ë¤Î»þ¤Ë¾¯¤·ÃíÌܤµ¤ì¤Þ¤·¤¿¤¬¡¢HPV¥ï¥¯¥Á¥ó¤Ç¤Ï¤¢¤Þ¤êÏÃÂê¤Ë¤Ê¤ê¤Þ¤»¤ó¡£
ÆüËܤÇǧ²Ä¤µ¤ì¤Æ¤¤¤ëHPV¥ï¥¯¥Á¥ó¤Î¥µ¡¼¥Ð¥ê¥Ã¥¯¥¹¤Ë´Þ¤Þ¤ì¤Æ¤¤¤ë¥¢¥¸¥å¥Ð¥ó¥È¤¬¡¢½÷À¤ÎÌȱ֤˱ƶÁ¤òÍ¿¤¨¡¢Î®»º¤Î¥ê¥¹¥¯¤Ë¤Ä¤Ê¤¬¤ë¤«¤É¤¦¤«¤Ë¤Ä¤¤¤Æ¤ÎÄ´ºº¤Î·ë²Ì¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials
Ä´ºº¤Ï14¥ö¹ñ¤Î15-25ºÐ½÷À26000¿Íµ¬ÌϤǹԤï¤ì¡¢4ǯ¤Î´Ñ»¡´ü´ÖÃæ¤Ë3599¤ÎÇ¥¿±¤¬¤ª¤¤Þ¤·¤¿¡£
Á´ÂΤȤ·¤Æ¤ÏÀܼﷲ¤ÈÈóÀܼﷲ¤Îή»º¤Î¥ê¥¹¥¯¤Ë¤Á¤¬¤¤¤Ï¤Ê¤·¡£¡Ê11.5¡ó¡¡VS¡¡10.2¡ó¡Ë¡£
ºÇ¸å¤ÎÀܼ狼¤é£³¥ö·î°ÊÆâ¤Îή»º¤Î¥ê¥¹¥¯¤ÏÀܼﷲ¤¬ÈóÀܼﷲ¤è¤ê¤â¹â¤¤¤³¤È¤¬»ØŦ¤µ¤ì¤Þ¤·¤¿¡Ê14.7¡ó VS¡¡9.1¡ó¡Ë¡£
¤¤¤º¤ì¤Ë¤·¤Æ¤â¡¢¥ï¥¯¥Á¥óÀܼïÁ°¸å¤Ç¤¢¤Ã¤Æ¤â¡Ö¥³¥ó¥É¡¼¥à¤ò¤Ï¤º¤µ¤Ê¤¤¤è¤¦¤Ë¡×¤ÏÈòÇ¥¤Ë¤â´¶À÷ͽËɤˤâ½ÅÍס£
ÅöÌôºÞÉô¤Ç¤Ï¡¢º£²ó¤Î¥µ¡¼¥Ð¥ê¥Ã¥¯¥¹¤Èή»ºÈ¯¾É¥ê¥¹¥¯¾å¾º¤È¤Î´ØÏ¢À¤Ë´Ø¤¹¤ëÏÀʸ¤Ë¤Ä¤¤¤ÆGSK¤ËÂФ·¤Æ¡¢£³·î½é½Ü¤Ë¼ÁÌä¤òÃפ·¤Þ¤·¤¿¡£¤µ¤é¤Ë¡¢FDA¤Ç¤Ï2009ǯ10·î¤Î»þÅÀ¤Ç¡¢ÏÀʸ¤Î¥É¥é¥Õ¥È²òÀϤηë²Ì¤ò¤â¤È¤Ë¡¢£³¥«·î̤Ëþ¤Îή»º¥ê¥¹¥¯¾å¾º¤Ë´Ø¤¹¤ëÃí°Õ´µ¯¤ò½Ð¤·¤Æ¤¤¤Þ¤¹¡£
GSK¤Î²óÅú¤Ï¡¢Î®»º¥ê¥¹¥¯¾å¾º¤Ë¤Ä¤¤¤Æ¤ÏÌäÂê¤Ê¤·¡¢°å»Õ¡¢´µ¼Ô¤ËÂФ·¤Æ¤Î¾ðÊóÄ󶡤âɬÍפʤ·¤ÈÊÖÅú¤ò¼õ¤±¤Þ¤·¤¿¡£
¤·¤«¤·¡¢¥ê¥¹¥¯¤È¥Ù¥Í¥Õ¥£¥Ã¥È¤òÍý²ò¤·¤¿¤¦¤¨¤Ç¤Î¥ï¥¯¥Á¥óÀܼï¤ÏɬÍפȹͤ¨¤Þ¤¹¡£Àܼï´õ˾¼Ô¤ËÂФ·¤Æ¤Ï¡¢¤³¤Î¤è¤¦¤Ê¥ê¥¹¥¯¤Î¾ðÊó¤ÎÄ󶡤ϹԤï¤Ê¤¯¤Æ¤Ï¤Ê¤é¤Ê¤¤¤È¹Í¤¨¤Æ¤ª¤ê¤Þ¤¹¡£
ÆüËܤǤϡ¢Î®»º¤Î¥ê¥¹¥¯¾å¾º¤Ë´Ø¤¹¤ë¾ðÊó¤ÏÉú¤»¤é¤ì¤Æ¤¤¤ë¤Î¤¬¸½¾õ¤È¹Í¤¨¤é¤ì¤Þ¤¹¡£
¤³¤Î·ï¤Ë´Ø¤¹¤ë¡¢ÀèÀ¸Êý¤Î¤´°Õ¸«¤ò¤¦¤«¤¬¤¨¤¿¤é¹¬¤¤¤Ç¤¹¡£
¾ðÊ󤢤꤬¤È¤¦¤´¤¶¤¤¤Þ¤¹¡£ÌôºÞ»Õ¤µ¤ó¤Î¸ºß¤Ï¤¿¤¤¤Ø¤ó¿´¶¯¤¤¤Ç¤¹¡£
¸½ºß¡¢½¸ÃÄÀܼï¤ò½àÈ÷¤·¤Æ¤¤¤ë¼«¼£ÂΤδط¸¼Ô¤ä¡¢É±¡¤ÇHPV¥ï¥¯¥Á¥ó¤Ë´Ø¤ï¤Ã¤Æ¤¤¤ë¥Ê¡¼¥¹¤Ë¤É¤Î¤è¤¦¤ÊÀâÌÀ¤ò¤·¤¿¤¦¤¨¤ÇƱ°Õ³Îǧ¤ò¤·¤Æ¤¤¤ë¤Î¤«¤¤¤¤Æ¤¤¤Þ¤¹¡£
°ìΧ¤ËÄ󶡤µ¤ì¤ë¤â¤Î¤È¡¢Ìä¿Ç¤ä¥¢¥»¥¹¥á¥ó¥È¤ÎÃæ¤ÇÄɲäÇ(¸ÄÊÌÀ¤Ë±þ¤¸¤Æ¡Ë³Îǧ¤ò¤·¤¿¤Û¤¦¤¬¤è¤¤¤³¤È¤È¤¢¤ë¤Î¤Ç¤Ï¤Ê¤¤¤«¤È¤¤¤¦¤³¤È¤ò´¶¤¸¤Æ¤¤¤Þ¤¹¡£
¤½¤Î¾ðÊó¤òÃΤë¥á¥ê¥Ã¥È¤Î¤¢¤ë¿Í¤Ë¡ÊÃΤé¤Ê¤¤¤È¥Ç¥á¥ê¥Ã¥È¤¬¤¢¤ê¤½¤¦¤Ê¿Í¤Ë¡Ë¾ðÊó¤ò¤¢¤¨¤Æ¸À¤ï¤Ê¤¤¤È¤¤¤¦¤³¤È¤Ï¡¢¥ê¥¹¥¯¤Îͽ¸«²ÄǽÀ¤È¤¤¤¦¤³¤È¤ÇÌäÂê¤Ë¤Ê¤ê¤¦¤ë¤³¤È¤Ê¤ó¤À¤È¤ª¤â¤¤¤Þ¤¹¤¬¡£
¾¤Î¤´°Õ¸«¤â¤¢¤ê¤Þ¤·¤¿¤é¤ªÂÔ¤Á¤·¤Æ¤ª¤ê¤Þ¤¹¡£